News Out PLAYA VISTA, Calif., Oct. 10, 2018 (GLOBE

New Post Public Reply Private Reply Replies (0) Message Board
sometimesoon
492
News Out

PLAYA VISTA, Calif., Oct. 10, 2018 (GLOBE NEWSWIRE) -- American Premium Water Corporation (OTC Pink: HIPH) (the Company ) announces that SeeThruEquity has revised upwards its initial price target for the Company from $0.15 to a revised target price of $0.30, with the report adding, "intriguing speculative growth company, targeting large consumer opportunities with the launch of LALPINA Hydro CBD and its subsequent ecommerce distribution announcements with SingleSeed.com and DIGSHydro.com, subsidiaries of SinglePoint, Inc, as well as strategic deals expanding the company s presence in the luxury consumer markets.
Ryan Fishoff, American Premium Water CEO, commented, Having American Premium s price target revised upward by SeeThruEquity is a validation of management s current plan. Over the past year, HIPH has transformed, entered one of the fastest growing sectors of the American economy (CBD), significantly reduced debt levels, made strategic acquisitions, entered into substantial distribution agreements, and, most importantly, positioned itself for substantial growth. The Company welcomes SeeThruEquity's continued research coverage and looks forward to supplying its analysts with more developments as we continue achieving our business plan targets in the near future.
SeeThruEquity analysts have placed a price target on HIPH common shares at $0.30, which represents a potential upside of 471.4% from the recent price of $0.0525 on Oct. 9, 2018. In the report, the firm further outlines expectations for the Company, as the launch of its CBD beverage enables HIPH to enter the large and rapidly growing CBD market, which, in the U.S., generated sales of $820 million in 2017 and is projected to grow at a compounded rate of 54% to reach $3 billion by 2020, according to Greenware Advisors. The firm also highlights potential growth on the pharma side, as HIPH is optimistic it will benefit from the recent DEA action removing CBD as Schedule 1 drug when there is 0.1% or less trace amounts of THC. Such products will now be classified as Schedule 5 drugs, as long as the medications have been approved by the FDA. While LALPINA Hydro CBD is not FDA-approved, it contains non-detectable amounts of THC, and HIPH may now be in a position to explore partnerships for medical applications of a formulation of its product. The full report can be viewed at http://www.seethruequity.com.
Management and the Company share SeeThru s belief that the CBD market presents a tremendous growth opportunity. As I ve said before, I believe HIPH has the combination of a unique product like LALPINA Hydro CBD, which is the only hydro-nano CBD product on the market, and the proven ability to successfully market a beverage brand that will separate the Company from others in the short and long term.
American Premium Water Corp. is the public holding trading company that owns LALPINA HYDRO, LALPINA HYDRO CBD, Gents, Worthy and FashionCoinX.
Safe Harbor Notice Certain statements contained herein are forward-looking statements (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC" EDGAR database.
This press release is issued on behalf of the Board of Directors of American Premium Water Corporation
Ryan Fishoff email: info@americanpremiumwater.com +1(888) 983-0054
Image: American-Premium-Water-Corp logo.jpg
Source: American Premium Water Corporation
Copyright 2018, GlobeNewswire News Provided by Acquire Media Corporatio

American Premium Water Corporation (HIPH) Stock Research Links

HIPH Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Home Repair Shock: 85% Hit by Unplanned Costs in 2025

Updated Category News Views 142

New findings hit the floor: a staggering 85% of American homeowners coughed up cash for unplanned repairs in 2025. That’s not just pocket change; over one-third, about 38%, forked out at least $5,000 on home renovation projects. And if you're thinking that's a fluke, wait until you hear that nearly a quarter of folks (23%) dug even deeper, spending upwards of $10,000....

Continue Reading
Genialis and Debiopharm Expand Collaboration for Cancer Drug Innovation

Updated Category News Views 150

Genialis and Debiopharm's Strategic Collaboration Genialis, a pioneering RNA biomarker company, has recently announced an exciting extension of its collaboration with Debiopharm, a global biopharmaceutical leader. This partnership aims to develop predictive biomarkers specifically for therapies targeting the WEE1 protein, which is crucial in the treatment landscape of...

Continue Reading
Telecom Providers Fight Robocalls with Enhanced Solutions

Updated Category News Views 411

Progress in Robocall Mitigation by Major Telecom Providers In recent developments, top US telecom providers such as Verizon, UScellular, T-Mobile, Lumen, Comcast, Charter, and AT&T have made significant strides in maximizing their efforts against robocalls. This progress is largely attributed to the successful implementation of the STIR/SHAKEN framework, which aids in...

Continue Reading
OpenSea Unveils OS2: A Major Step Forward with $SEA Token

Updated Category News Views 238

OpenSea Launches OS2 Platform with Enhanced Trading Features The innovative marketplace, OpenSea, has rolled out its new platform known as OS2, which represents a significant transformation from its original NFT-centric model into a comprehensive trading space. This upgrade broadens its scope, allowing not just the buying and selling of NFTs but also the trading of...

Continue Reading
Experience the Future of Communications at Telecoms World Asia

Updated Category News Views 44

Join DIDWW at Telecommunications World Asia DIDWW, a renowned global provider of premium VoIP communications, is set to showcase its innovative voice and SMS solutions at the upcoming Telecoms World Asia event. This exhibition represents an incredible opportunity for telecommunications experts and businesses looking to enhance their communication strategies. What to...

Continue Reading